BNP Paribas Discount Zert MRNA 27.../ DE000PN53VQ7 /
20/06/2024 21:40:22 | Chg.+0.220 | Bid21:54:20 | Ask21:54:20 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
83.890EUR | +0.26% | - Bid Size: - |
- Ask Size: - |
Moderna Inc | - USD | 27/06/2024 | Call |
GlobeNewswire
13/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire
05/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire
22/05
Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
GlobeNewswire
12/05
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire
08/05
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08/05
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
02/05
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
01/05
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GlobeNewswire
04/04
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...
GlobeNewswire
04/03
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024